Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Curr Protoc ; 3(6): e799, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37327316

ABSTRACT

S-Adenosyl-L-methionine (AdoMet) is a ubiquitous methyl donor for a variety of biological methylation reactions catalyzed by methyltransferases (MTases). AdoMet analogs with extended propargylic chains replacing the sulfonium-bound methyl group can serve as surrogate cofactors for many DNA and RNA MTases, enabling covalent derivatization and subsequent labeling of their cognate target sites in DNA or RNA. Although AdoMet analogs with saturated aliphatic chains are less popular than propargylic ones, they can be useful for dedicated studies that require certain chemical derivatization. Here we describe synthetic procedures for the preparation of two AdoMet analogs, one with a transferable 6-azidohex-2-ynyl group (carrying an activating C≡C triple bond and a terminal azide functionality), and the other one with a transferable ethyl-2,2,2-d3 group (an isotope-labeled aliphatic moiety). Our synthetic approach is based on direct chemoselective alkylation of S-adenosyl-L-homocysteine at sulfur with a corresponding nosylate or triflate, respectively, under acidic conditions. We also describe synthetic routes to 6-azidohex-2-yn-1-ol and conversion of the alcohols to corresponding nosylate and triflate alkylators. Using these protocols, the synthetic AdoMet analogs can be prepared within 1 to 2 weeks. © 2023 Wiley Periodicals LLC. Basic Protocol 1: Synthesis of 6-azidohex-2-yn-1-ol Basic Protocol 2: Synthesis of 4-nitrobenzenesulfonate Basic Protocol 3: Synthesis of trifluoromethanesulfonates Basic Protocol 4: S-Alkylation of AdoHcy with sulfonates Basic Protocol 5: Purification and characterization of AdoMet analogs.


Subject(s)
Methyltransferases , S-Adenosylmethionine , Methyltransferases/chemistry , S-Adenosylmethionine/chemistry , Methionine , RNA/chemistry , DNA/chemistry , Racemethionine
2.
RSC Adv ; 13(21): 14370-14378, 2023 May 09.
Article in English | MEDLINE | ID: mdl-37180021

ABSTRACT

All-inorganic lead perovskite quantum dots (QDs), due to their distinctive optical properties, have become one of the "hottest" topics in materials science; therefore, the development of new QD synthesis methods or their emission color adjustment is of great interest. Within this study, we present the simple preparation of QDs employing a novel ultrasound-induced hot-injection method, which significantly reduces the QD synthesis time from several hours to merely 15-20 minutes. Moreover, the post-synthesis treatment of perovskite QDs in solutions using zinc halogenide complexes could increase the QD emission intensity and, at the same time, boost their quantum efficiency. This behavior is due to the zinc halogenide complex's ability to remove or significantly reduce the number of surface electron traps in perovskite QDs. Finally, the experiment that shows the ability to instantly adjust the desired emission color of perovskite QDs by variation of the amount of added zinc halogenide complex is presented. The instantly obtained perovskite QD colors cover virtually the full range of the visible spectrum. The zinc halogenide modified perovskite QDs exhibit up to 10-15% higher QEs than those prepared by an individual synthesis.

SELECTION OF CITATIONS
SEARCH DETAIL